The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa.

The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa.

<h4>Background</h4>Intermittent preventive treatment in infants (IPTi) has been shown to decrease clinical malaria by approximately 30% in the first year of life and is a promising malaria control strategy for Sub-Saharan Africa which can be delivered alongside the Expanded Programme on...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lesong Conteh, Elisa Sicuri, Fatuma Manzi, Guy Hutton, Benson Obonyo, Fabrizio Tediosi, Prosper Biao, Paul Masika, Fred Matovu, Peter Otieno, Roly D Gosling, Mary Hamel, Frank O Odhiambo, Martin P Grobusch, Peter G Kremsner, Daniel Chandramohan, John J Aponte, Andrea Egan, David Schellenberg, Eusebio Macete, Laurence Slutsker, Robert D Newman, Pedro Alonso, Clara Menéndez, Marcel Tanner
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2010
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/ea1b8c712c8542b1898eec17750b3790
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ea1b8c712c8542b1898eec17750b3790
record_format dspace
spelling oai:doaj.org-article:ea1b8c712c8542b1898eec17750b37902021-12-02T20:20:48ZThe cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa.1932-620310.1371/journal.pone.0010313https://doaj.org/article/ea1b8c712c8542b1898eec17750b37902010-06-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20559558/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Intermittent preventive treatment in infants (IPTi) has been shown to decrease clinical malaria by approximately 30% in the first year of life and is a promising malaria control strategy for Sub-Saharan Africa which can be delivered alongside the Expanded Programme on Immunisation (EPI). To date, there have been limited data on the cost-effectiveness of this strategy using sulfadoxine pyrimethamine (SP) and no published data on cost-effectiveness using other antimalarials.<h4>Methods</h4>We analysed data from 5 countries in sub-Saharan Africa using a total of 5 different IPTi drug regimens; SP, mefloquine (MQ), 3 days of chlorproguanil-dapsone (CD), SP plus 3 days of artesunate (SP-AS3) and 3 days of amodiaquine-artesunate (AQ3-AS3).The cost per malaria episode averted and cost per Disability-Adjusted Life-Year (DALY) averted were modeled using both trial specific protective efficacy (PE) for all IPTi drugs and a pooled PE for IPTi with SP, malaria incidence, an estimated malaria case fatality rate of 1.57%, IPTi delivery costs and country specific provider and household malaria treatment costs.<h4>Findings</h4>In sites where IPTi had a significant effect on reducing malaria, the cost per episode averted for IPTi-SP was very low, USD 1.36-4.03 based on trial specific data and USD 0.68-2.27 based on the pooled analysis. For IPTi using alternative antimalarials, the lowest cost per case averted was for AQ3-AS3 in western Kenya (USD 4.62) and the highest was for MQ in Korowge, Tanzania (USD 18.56). Where efficacious, based only on intervention costs, IPTi was shown to be cost effective in all the sites and highly cost-effective in all but one of the sites, ranging from USD 2.90 (Ifakara, Tanzania with SP) to USD 39.63 (Korogwe, Tanzania with MQ) per DALY averted. In addition, IPTi reduced health system costs and showed significant savings to households from malaria cases averted. A threshold analysis showed that there is room for the IPTi-efficacy to fall and still remain highly cost effective in all sites where IPTi had a statistically significant effect on clinical malaria.<h4>Conclusions</h4>IPTi delivered alongside the EPI is a highly cost effective intervention against clinical malaria with a range of drugs in a range of malaria transmission settings. Where IPTi did not have a statistically significant impact on malaria, generally in low transmission sites, it was not cost effective.Lesong ContehElisa SicuriFatuma ManziGuy HuttonBenson ObonyoFabrizio TediosiProsper BiaoPaul MasikaFred MatovuPeter OtienoRoly D GoslingMary HamelFrank O OdhiamboMartin P GrobuschPeter G KremsnerDaniel ChandramohanJohn J AponteAndrea EganDavid SchellenbergEusebio MaceteLaurence SlutskerRobert D NewmanPedro AlonsoClara MenéndezMarcel TannerPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 5, Iss 6, p e10313 (2010)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Lesong Conteh
Elisa Sicuri
Fatuma Manzi
Guy Hutton
Benson Obonyo
Fabrizio Tediosi
Prosper Biao
Paul Masika
Fred Matovu
Peter Otieno
Roly D Gosling
Mary Hamel
Frank O Odhiambo
Martin P Grobusch
Peter G Kremsner
Daniel Chandramohan
John J Aponte
Andrea Egan
David Schellenberg
Eusebio Macete
Laurence Slutsker
Robert D Newman
Pedro Alonso
Clara Menéndez
Marcel Tanner
The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa.
description <h4>Background</h4>Intermittent preventive treatment in infants (IPTi) has been shown to decrease clinical malaria by approximately 30% in the first year of life and is a promising malaria control strategy for Sub-Saharan Africa which can be delivered alongside the Expanded Programme on Immunisation (EPI). To date, there have been limited data on the cost-effectiveness of this strategy using sulfadoxine pyrimethamine (SP) and no published data on cost-effectiveness using other antimalarials.<h4>Methods</h4>We analysed data from 5 countries in sub-Saharan Africa using a total of 5 different IPTi drug regimens; SP, mefloquine (MQ), 3 days of chlorproguanil-dapsone (CD), SP plus 3 days of artesunate (SP-AS3) and 3 days of amodiaquine-artesunate (AQ3-AS3).The cost per malaria episode averted and cost per Disability-Adjusted Life-Year (DALY) averted were modeled using both trial specific protective efficacy (PE) for all IPTi drugs and a pooled PE for IPTi with SP, malaria incidence, an estimated malaria case fatality rate of 1.57%, IPTi delivery costs and country specific provider and household malaria treatment costs.<h4>Findings</h4>In sites where IPTi had a significant effect on reducing malaria, the cost per episode averted for IPTi-SP was very low, USD 1.36-4.03 based on trial specific data and USD 0.68-2.27 based on the pooled analysis. For IPTi using alternative antimalarials, the lowest cost per case averted was for AQ3-AS3 in western Kenya (USD 4.62) and the highest was for MQ in Korowge, Tanzania (USD 18.56). Where efficacious, based only on intervention costs, IPTi was shown to be cost effective in all the sites and highly cost-effective in all but one of the sites, ranging from USD 2.90 (Ifakara, Tanzania with SP) to USD 39.63 (Korogwe, Tanzania with MQ) per DALY averted. In addition, IPTi reduced health system costs and showed significant savings to households from malaria cases averted. A threshold analysis showed that there is room for the IPTi-efficacy to fall and still remain highly cost effective in all sites where IPTi had a statistically significant effect on clinical malaria.<h4>Conclusions</h4>IPTi delivered alongside the EPI is a highly cost effective intervention against clinical malaria with a range of drugs in a range of malaria transmission settings. Where IPTi did not have a statistically significant impact on malaria, generally in low transmission sites, it was not cost effective.
format article
author Lesong Conteh
Elisa Sicuri
Fatuma Manzi
Guy Hutton
Benson Obonyo
Fabrizio Tediosi
Prosper Biao
Paul Masika
Fred Matovu
Peter Otieno
Roly D Gosling
Mary Hamel
Frank O Odhiambo
Martin P Grobusch
Peter G Kremsner
Daniel Chandramohan
John J Aponte
Andrea Egan
David Schellenberg
Eusebio Macete
Laurence Slutsker
Robert D Newman
Pedro Alonso
Clara Menéndez
Marcel Tanner
author_facet Lesong Conteh
Elisa Sicuri
Fatuma Manzi
Guy Hutton
Benson Obonyo
Fabrizio Tediosi
Prosper Biao
Paul Masika
Fred Matovu
Peter Otieno
Roly D Gosling
Mary Hamel
Frank O Odhiambo
Martin P Grobusch
Peter G Kremsner
Daniel Chandramohan
John J Aponte
Andrea Egan
David Schellenberg
Eusebio Macete
Laurence Slutsker
Robert D Newman
Pedro Alonso
Clara Menéndez
Marcel Tanner
author_sort Lesong Conteh
title The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa.
title_short The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa.
title_full The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa.
title_fullStr The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa.
title_full_unstemmed The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa.
title_sort cost-effectiveness of intermittent preventive treatment for malaria in infants in sub-saharan africa.
publisher Public Library of Science (PLoS)
publishDate 2010
url https://doaj.org/article/ea1b8c712c8542b1898eec17750b3790
work_keys_str_mv AT lesongconteh thecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT elisasicuri thecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT fatumamanzi thecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT guyhutton thecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT bensonobonyo thecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT fabriziotediosi thecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT prosperbiao thecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT paulmasika thecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT fredmatovu thecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT peterotieno thecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT rolydgosling thecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT maryhamel thecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT frankoodhiambo thecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT martinpgrobusch thecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT petergkremsner thecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT danielchandramohan thecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT johnjaponte thecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT andreaegan thecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT davidschellenberg thecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT eusebiomacete thecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT laurenceslutsker thecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT robertdnewman thecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT pedroalonso thecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT claramenendez thecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT marceltanner thecosteffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT lesongconteh costeffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT elisasicuri costeffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT fatumamanzi costeffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT guyhutton costeffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT bensonobonyo costeffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT fabriziotediosi costeffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT prosperbiao costeffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT paulmasika costeffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT fredmatovu costeffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT peterotieno costeffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT rolydgosling costeffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT maryhamel costeffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT frankoodhiambo costeffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT martinpgrobusch costeffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT petergkremsner costeffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT danielchandramohan costeffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT johnjaponte costeffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT andreaegan costeffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT davidschellenberg costeffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT eusebiomacete costeffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT laurenceslutsker costeffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT robertdnewman costeffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT pedroalonso costeffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT claramenendez costeffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
AT marceltanner costeffectivenessofintermittentpreventivetreatmentformalariaininfantsinsubsaharanafrica
_version_ 1718374200895340544

Ejemplares similares